FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893147769> ?p ?o ?g. }

• W2893147769 abstract "Background; Peripheral artery disease causes significant functional disability and results in impaired quality of life. Ischemic tissue injury releases various endogenous ligands for Toll-like receptors (TLRs), suggesting the involvement of TLRs in blood flow recovery. However, the role of TLR9, which was originally known as a sensor for bacterial DNA, remains unknown. This study investigated the role of TLR9 in blood flow recovery in the ischemic limb using a mouse hind-limb ischemia model. Methods and Results; Unilateral femoral artery ligation was performed in TLR9-deficient (Tlr9-/-) mice and wild-type mice. In wild-type mice, femoral artery ligation significantly increased mRNA expression of TLR9 in the ischemic limb (P < 0.001) and plasma levels of cell-free DNA (cfDNA) as determined by single-stranded DNA (ssDNA) (P < 0.05) and double-stranded DNA (dsDNA) (P < 0.01), which are endogenous ligands for TLR9, compared with the sham-operated group. Laser Doppler perfusion imaging demonstrated significantly improved ratio of blood flow in the ischemic to non-ischemic limb in TLR9-/- mice compared with wild-type mice at 2 weeks after ligation (P < 0.05). Tlr9-/- mice showed increased capillary density and reduced macrophage infiltration in ischemic limb. Genetic deletion of TLR9 reduced the expression of TNF-, and attenuated NF-B activation in ischemic muscle compared with wild-type mice (P < 0.05, respectively) at 3 days after the surgery. ODN1826, a synthetic agonistic oligonucleotide for TLR9, or plasma obtained from mice with ischemic muscle promoted the expression of TNF- in wild-type macrophages (P < 0.05), but not in Tlr9-/- macrophages. ODN1826 also activated NF-B signaling as determined by the degradation of IB in wild-type macrophages (P < 0.05), but not in Tlr9-/- macrophages. In vitro experiments using human umbilical vein endothelial cells demonstrated that TNF-, or conditioned medium obtained from wild-type macrophages treated with ODN1826 accelerated cell death as determined by MTS assay (P < 0.05 and P < 0.01, respectively). Conclusion; Our results suggest that ischemic muscle releases cfDNA, which activates TLR9 and enhances inflammation, leading to impairment of blood flow recovery in the ischemic limb. cfDNA-TLR9 signaling may serve as a potential therapeutic target in ischemic limb disease." @default.
• W2893147769 created "2018-10-05" @default.
• W2893147769 creator A5021036967 @default.
• W2893147769 creator A5026286727 @default.
• W2893147769 creator A5044995720 @default.
• W2893147769 creator A5047611581 @default.
• W2893147769 creator A5064352455 @default.
• W2893147769 creator A5073291028 @default.
• W2893147769 creator A5078739904 @default.
• W2893147769 creator A5081556515 @default.
• W2893147769 creator A5084671369 @default.
• W2893147769 creator A5088510144 @default.
• W2893147769 creator A5089437525 @default.
• W2893147769 creator A5091249720 @default.
• W2893147769 date "2018-10-16" @default.
• W2893147769 modified "2023-10-01" @default.
• W2893147769 title "Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia" @default.
• W2893147769 cites W1274671738 @default.
• W2893147769 cites W1514540900 @default.
• W2893147769 cites W1868478050 @default.
• W2893147769 cites W1943227576 @default.
• W2893147769 cites W1964107683 @default.
• W2893147769 cites W1969763429 @default.
• W2893147769 cites W1970017835 @default.
• W2893147769 cites W1977659720 @default.
• W2893147769 cites W1985477675 @default.
• W2893147769 cites W1986316483 @default.
• W2893147769 cites W1995744610 @default.
• W2893147769 cites W2006122359 @default.
• W2893147769 cites W2007751980 @default.
• W2893147769 cites W2008960002 @default.
• W2893147769 cites W2012212705 @default.
• W2893147769 cites W2031084334 @default.
• W2893147769 cites W2038073973 @default.
• W2893147769 cites W2042851093 @default.
• W2893147769 cites W204998232 @default.
• W2893147769 cites W2065501665 @default.
• W2893147769 cites W2065878448 @default.
• W2893147769 cites W2071309317 @default.
• W2893147769 cites W2078338047 @default.
• W2893147769 cites W2105415988 @default.
• W2893147769 cites W2118011548 @default.
• W2893147769 cites W2129708174 @default.
• W2893147769 cites W2131275094 @default.
• W2893147769 cites W2131525958 @default.
• W2893147769 cites W2133800545 @default.
• W2893147769 cites W2144474790 @default.
• W2893147769 cites W2159574720 @default.
• W2893147769 cites W2159753138 @default.
• W2893147769 cites W2163463787 @default.
• W2893147769 cites W2163714734 @default.
• W2893147769 cites W2166109718 @default.
• W2893147769 cites W2168833608 @default.
• W2893147769 cites W2309306045 @default.
• W2893147769 cites W2418259125 @default.
• W2893147769 doi "https://doi.org/10.3389/fcvm.2018.00144" @default.
• W2893147769 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6232671" @default.
• W2893147769 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30460242" @default.
• W2893147769 hasPublicationYear "2018" @default.
• W2893147769 type Work @default.
• W2893147769 sameAs 2893147769 @default.
• W2893147769 citedByCount "7" @default.
• W2893147769 countsByYear W28931477692020 @default.
• W2893147769 countsByYear W28931477692021 @default.
• W2893147769 countsByYear W28931477692022 @default.
• W2893147769 countsByYear W28931477692023 @default.
• W2893147769 crossrefType "journal-article" @default.
• W2893147769 hasAuthorship W2893147769A5021036967 @default.
• W2893147769 hasAuthorship W2893147769A5026286727 @default.
• W2893147769 hasAuthorship W2893147769A5044995720 @default.
• W2893147769 hasAuthorship W2893147769A5047611581 @default.
• W2893147769 hasAuthorship W2893147769A5064352455 @default.
• W2893147769 hasAuthorship W2893147769A5073291028 @default.
• W2893147769 hasAuthorship W2893147769A5078739904 @default.
• W2893147769 hasAuthorship W2893147769A5081556515 @default.
• W2893147769 hasAuthorship W2893147769A5084671369 @default.
• W2893147769 hasAuthorship W2893147769A5088510144 @default.
• W2893147769 hasAuthorship W2893147769A5089437525 @default.
• W2893147769 hasAuthorship W2893147769A5091249720 @default.
• W2893147769 hasBestOaLocation W28931477691 @default.
• W2893147769 hasConcept C104317684 @default.
• W2893147769 hasConcept C126322002 @default.
• W2893147769 hasConcept C134018914 @default.
• W2893147769 hasConcept C142724271 @default.
• W2893147769 hasConcept C150194340 @default.
• W2893147769 hasConcept C158846371 @default.
• W2893147769 hasConcept C170493617 @default.
• W2893147769 hasConcept C179437574 @default.
• W2893147769 hasConcept C190727270 @default.
• W2893147769 hasConcept C2776070231 @default.
• W2893147769 hasConcept C2776914184 @default.
• W2893147769 hasConcept C2779138994 @default.
• W2893147769 hasConcept C541997718 @default.
• W2893147769 hasConcept C55493867 @default.
• W2893147769 hasConcept C71924100 @default.
• W2893147769 hasConcept C86803240 @default.
• W2893147769 hasConceptScore W2893147769C104317684 @default.
• W2893147769 hasConceptScore W2893147769C126322002 @default.
• W2893147769 hasConceptScore W2893147769C134018914 @default.
• W2893147769 hasConceptScore W2893147769C142724271 @default.

• next